Xenetic Biosciences Appoints Timothy Cote, MD, MPH, Former Head Of FDA Orphan Drug Division, To Board Of Directors
2/10/2014 9:20:59 AM
LEXINGTON, Mass., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Xenetic Biosciences, Inc. (OTCBB:GAIFD), a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics, today announced the appointment of Timothy Coté, MD, MPH, to the company's Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by